You are here

  • Home
  • Archive
  • Volume 1, Issue Suppl 1
  • Pre-treatment serum vascular endothelial growth factor is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumab

Article metrics

Article menu

Download PDFPDF

Poster Presentation
Pre-treatment serum vascular endothelial growth factor is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumab
Free

 

Online download statistics by month:

Online download statistics by month: December 2019 to November 2024

AbstractFullPdf
Dec 2019020
Jan 2020042
Feb 2020031
Mar 2020010
Apr 2020031
May 2020060
Jun 20200320
Jul 2020030
Aug 2020011
Sep 2020080
Oct 2020010
Dec 2020040
Jan 2021010
Feb 2021011
Mar 2021022
Apr 2021021
May 2021031
Jun 2021050
Jul 2021040
Sep 2021040
Oct 2021040
Nov 2021074
Dec 2021060
Jan 2022070
Feb 2022020
Mar 2022031
Apr 2022081
May 20220211
Jun 20220172
Jul 20220112
Aug 2022071
Sep 20220131
Oct 20220100
Nov 202201111
Dec 2022061
Jan 2023042
Feb 20230230
Mar 2023041
Jun 2023010
Jul 2023011
Aug 2023001
Sep 2023021
Oct 2023013
Nov 2023059
Dec 2023061
Jan 2024071
Feb 2024070
Mar 20240629
Apr 202401122
May 2024076
Jun 2024010
Jul 20240112
Aug 2024052
Sep 2024052
Oct 2024050
Nov 2024074
Total0342122